The role of homocysteine in the clinical assessment of cardiovascular risk

Br J Cardiol 2003;10:118-22 Leave a comment
Click any image to enlarge
Authors:

Clinical and epidemiological studies suggest elevated levels of total plasma homocysteine (> 15 µmol/L) are associated with an increased risk of cardiovascular disease, independent of other known risk factors. This review outlines the causes of hyperhomocysteinaemia, current evidence of a positive association with cardiovascular disease, and how such findings may have important implications for future assessments of risk and nutritional recommendations, particularly for those with a previous or family history of cardiovascular disease.

Advertisement
Angina - BJC Learning programme
For healthcare professionals only

THERE ARE CURRENTLY NO COMMENTS FOR THIS ARTICLE - LEAVE A COMMENT